XFOR - X4 slips after mid-stage data for lead drug in neutropenia
2024-06-27 13:40:16 ET
More on X4 Pharmaceuticals
- X4 Pharmaceuticals Inc (XFOR) Q1 2024 Earnings Call Transcript
- X4 Pharmaceuticals: FDA Approval For WHIM Warrants Further Upside
- X4 Pharmaceuticals: PDUFA Excitement Ahead
- X4 Pharma gains on new $125 financing
- X4 Pharmaceuticals GAAP EPS of -$0.26